Industry: Medical Devices & Consumables
Published Date: 2025-05-02
Pages: 129 Pages
Report ld: 4722071
Request Sample
Customized Report
Nuclear Medicine Shielded Equipment Market Size(US$)

CAGR 2025-2031
8.2%
Market Size,2031
USD 218
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Nuclear Medicine Shielded Equipment was estimated to be worth US$ 128 million in 2024 and is forecast to a readjusted size of US$ 218 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Nuclear Medicine Shielded Equipment cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Nuclear Medicine Shielded Equipment refers to specialized devices crafted from materials like lead, concrete, or lead-glass. These are designed to block and absorb gamma, beta, and other ionizing radiations during nuclear medicine procedures, safeguarding patients, medical staff, and the public from harmful radiation exposure.
North American market for Nuclear Medicine Shielded Equipment was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Nuclear Medicine Shielded Equipment was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Nuclear Medicine Shielded Equipment was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Nuclear Medicine Shielded Equipment include Comecer S.p.A., Tema Sinergie, Trasis, Norer Shield Medical, Mirion, Ultraray Radiation Protection, Von Gahlen, Lemer Pax, Beijing Zhonghe Yongtai Technology, Bequerel & Sievert, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine Shielded Equipment, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Nuclear Medicine Shielded Equipment by region & country, by Type, and by Application.
The Nuclear Medicine Shielded Equipment market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine Shielded Equipment.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Nuclear Medicine Shielded Equipment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Nuclear Medicine Shielded Equipment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Nuclear Medicine Shielded Equipment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Nuclear Medicine Shielded Equipment Product Introduction
1.2 Global Nuclear Medicine Shielded Equipment Market Size Forecast
1.2.1 Global Nuclear Medicine Shielded Equipment Sales Value (2020-2031)
1.2.2 Global Nuclear Medicine Shielded Equipment Sales Volume (2020-2031)
1.2.3 Global Nuclear Medicine Shielded Equipment Sales Price (2020-2031)
1.3 Nuclear Medicine Shielded Equipment Market Trends & Drivers
1.3.1 Nuclear Medicine Shielded Equipment Industry Trends
1.3.2 Nuclear Medicine Shielded Equipment Market Drivers & Opportunity
1.3.3 Nuclear Medicine Shielded Equipment Market Challenges
1.3.4 Nuclear Medicine Shielded Equipment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Nuclear Medicine Shielded Equipment Players Revenue Ranking (2024)
2.2 Global Nuclear Medicine Shielded Equipment Revenue by Company (2020-2025)
2.3 Global Nuclear Medicine Shielded Equipment Players Sales Volume Ranking (2024)
2.4 Global Nuclear Medicine Shielded Equipment Sales Volume by Company Players (2020-2025)
2.5 Global Nuclear Medicine Shielded Equipment Average Price by Company (2020-2025)
2.6 Key Manufacturers Nuclear Medicine Shielded Equipment Manufacturing Base and Headquarters
2.7 Key Manufacturers Nuclear Medicine Shielded Equipment Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Nuclear Medicine Shielded Equipment
2.9 Nuclear Medicine Shielded Equipment Market Competitive Analysis
2.9.1 Nuclear Medicine Shielded Equipment Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Nuclear Medicine Shielded Equipment Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Shielded Equipment as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Fully Automatic
3.1.2 Semi-automatic
3.2 Global Nuclear Medicine Shielded Equipment Sales Value by Type
3.2.1 Global Nuclear Medicine Shielded Equipment Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Nuclear Medicine Shielded Equipment Sales Value, by Type (2020-2031)
3.2.3 Global Nuclear Medicine Shielded Equipment Sales Value, by Type (%) (2020-2031)
3.3 Global Nuclear Medicine Shielded Equipment Sales Volume by Type
3.3.1 Global Nuclear Medicine Shielded Equipment Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Nuclear Medicine Shielded Equipment Sales Volume, by Type (2020-2031)
3.3.3 Global Nuclear Medicine Shielded Equipment Sales Volume, by Type (%) (2020-2031)
3.4 Global Nuclear Medicine Shielded Equipment Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical
4.1.2 Hospital
4.1.3 Research
4.2 Global Nuclear Medicine Shielded Equipment Sales Value by Application
4.2.1 Global Nuclear Medicine Shielded Equipment Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Nuclear Medicine Shielded Equipment Sales Value, by Application (2020-2031)
4.2.3 Global Nuclear Medicine Shielded Equipment Sales Value, by Application (%) (2020-2031)
4.3 Global Nuclear Medicine Shielded Equipment Sales Volume by Application
4.3.1 Global Nuclear Medicine Shielded Equipment Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Nuclear Medicine Shielded Equipment Sales Volume, by Application (2020-2031)
4.3.3 Global Nuclear Medicine Shielded Equipment Sales Volume, by Application (%) (2020-2031)
4.4 Global Nuclear Medicine Shielded Equipment Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Nuclear Medicine Shielded Equipment Sales Value by Region
5.1.1 Global Nuclear Medicine Shielded Equipment Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Nuclear Medicine Shielded Equipment Sales Value by Region (2020-2025)
5.1.3 Global Nuclear Medicine Shielded Equipment Sales Value by Region (2026-2031)
5.1.4 Global Nuclear Medicine Shielded Equipment Sales Value by Region (%), (2020-2031)
5.2 Global Nuclear Medicine Shielded Equipment Sales Volume by Region
5.2.1 Global Nuclear Medicine Shielded Equipment Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Nuclear Medicine Shielded Equipment Sales Volume by Region (2020-2025)
5.2.3 Global Nuclear Medicine Shielded Equipment Sales Volume by Region (2026-2031)
5.2.4 Global Nuclear Medicine Shielded Equipment Sales Volume by Region (%), (2020-2031)
5.3 Global Nuclear Medicine Shielded Equipment Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Nuclear Medicine Shielded Equipment Sales Value, 2020-2031
5.4.2 North America Nuclear Medicine Shielded Equipment Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Nuclear Medicine Shielded Equipment Sales Value, 2020-2031
5.5.2 Europe Nuclear Medicine Shielded Equipment Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Nuclear Medicine Shielded Equipment Sales Value, 2020-2031
5.6.2 Asia Pacific Nuclear Medicine Shielded Equipment Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Nuclear Medicine Shielded Equipment Sales Value, 2020-2031
5.7.2 South America Nuclear Medicine Shielded Equipment Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Nuclear Medicine Shielded Equipment Sales Value, 2020-2031
5.8.2 Middle East & Africa Nuclear Medicine Shielded Equipment Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Nuclear Medicine Shielded Equipment Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Nuclear Medicine Shielded Equipment Sales Value and Sales Volume
6.2.1 Key Countries/Regions Nuclear Medicine Shielded Equipment Sales Value, 2020-2031
6.2.2 Key Countries/Regions Nuclear Medicine Shielded Equipment Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Nuclear Medicine Shielded Equipment Sales Value, 2020-2031
6.3.2 United States Nuclear Medicine Shielded Equipment Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Nuclear Medicine Shielded Equipment Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Nuclear Medicine Shielded Equipment Sales Value, 2020-2031
6.4.2 Europe Nuclear Medicine Shielded Equipment Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Nuclear Medicine Shielded Equipment Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Nuclear Medicine Shielded Equipment Sales Value, 2020-2031
6.5.2 China Nuclear Medicine Shielded Equipment Sales Value by Type (%), 2024 VS 2031
6.5.3 China Nuclear Medicine Shielded Equipment Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Nuclear Medicine Shielded Equipment Sales Value, 2020-2031
6.6.2 Japan Nuclear Medicine Shielded Equipment Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Nuclear Medicine Shielded Equipment Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Nuclear Medicine Shielded Equipment Sales Value, 2020-2031
6.7.2 South Korea Nuclear Medicine Shielded Equipment Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Nuclear Medicine Shielded Equipment Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Nuclear Medicine Shielded Equipment Sales Value, 2020-2031
6.8.2 Southeast Asia Nuclear Medicine Shielded Equipment Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Nuclear Medicine Shielded Equipment Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Nuclear Medicine Shielded Equipment Sales Value, 2020-2031
6.9.2 India Nuclear Medicine Shielded Equipment Sales Value by Type (%), 2024 VS 2031
6.9.3 India Nuclear Medicine Shielded Equipment Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Comecer S.p.A.
7.1.1 Comecer S.p.A. Company Information
7.1.2 Comecer S.p.A. Introduction and Business Overview
7.1.3 Comecer S.p.A. Nuclear Medicine Shielded Equipment Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Comecer S.p.A. Nuclear Medicine Shielded Equipment Product Offerings
7.1.5 Comecer S.p.A. Recent Development
7.2 Tema Sinergie
7.2.1 Tema Sinergie Company Information
7.2.2 Tema Sinergie Introduction and Business Overview
7.2.3 Tema Sinergie Nuclear Medicine Shielded Equipment Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Tema Sinergie Nuclear Medicine Shielded Equipment Product Offerings
7.2.5 Tema Sinergie Recent Development
7.3 Trasis
7.3.1 Trasis Company Information
7.3.2 Trasis Introduction and Business Overview
7.3.3 Trasis Nuclear Medicine Shielded Equipment Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Trasis Nuclear Medicine Shielded Equipment Product Offerings
7.3.5 Trasis Recent Development
7.4 Norer Shield Medical
7.4.1 Norer Shield Medical Company Information
7.4.2 Norer Shield Medical Introduction and Business Overview
7.4.3 Norer Shield Medical Nuclear Medicine Shielded Equipment Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Norer Shield Medical Nuclear Medicine Shielded Equipment Product Offerings
7.4.5 Norer Shield Medical Recent Development
7.5 Mirion
7.5.1 Mirion Company Information
7.5.2 Mirion Introduction and Business Overview
7.5.3 Mirion Nuclear Medicine Shielded Equipment Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Mirion Nuclear Medicine Shielded Equipment Product Offerings
7.5.5 Mirion Recent Development
7.6 Ultraray Radiation Protection
7.6.1 Ultraray Radiation Protection Company Information
7.6.2 Ultraray Radiation Protection Introduction and Business Overview
7.6.3 Ultraray Radiation Protection Nuclear Medicine Shielded Equipment Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Ultraray Radiation Protection Nuclear Medicine Shielded Equipment Product Offerings
7.6.5 Ultraray Radiation Protection Recent Development
7.7 Von Gahlen
7.7.1 Von Gahlen Company Information
7.7.2 Von Gahlen Introduction and Business Overview
7.7.3 Von Gahlen Nuclear Medicine Shielded Equipment Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Von Gahlen Nuclear Medicine Shielded Equipment Product Offerings
7.7.5 Von Gahlen Recent Development
7.8 Lemer Pax
7.8.1 Lemer Pax Company Information
7.8.2 Lemer Pax Introduction and Business Overview
7.8.3 Lemer Pax Nuclear Medicine Shielded Equipment Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Lemer Pax Nuclear Medicine Shielded Equipment Product Offerings
7.8.5 Lemer Pax Recent Development
7.9 Beijing Zhonghe Yongtai Technology
7.9.1 Beijing Zhonghe Yongtai Technology Company Information
7.9.2 Beijing Zhonghe Yongtai Technology Introduction and Business Overview
7.9.3 Beijing Zhonghe Yongtai Technology Nuclear Medicine Shielded Equipment Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Beijing Zhonghe Yongtai Technology Nuclear Medicine Shielded Equipment Product Offerings
7.9.5 Beijing Zhonghe Yongtai Technology Recent Development
7.10 Bequerel & Sievert
7.10.1 Bequerel & Sievert Company Information
7.10.2 Bequerel & Sievert Introduction and Business Overview
7.10.3 Bequerel & Sievert Nuclear Medicine Shielded Equipment Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Bequerel & Sievert Nuclear Medicine Shielded Equipment Product Offerings
7.10.5 Bequerel & Sievert Recent Development
7.11 Tianjin Zhongfuan Technology
7.11.1 Tianjin Zhongfuan Technology Company Information
7.11.2 Tianjin Zhongfuan Technology Introduction and Business Overview
7.11.3 Tianjin Zhongfuan Technology Nuclear Medicine Shielded Equipment Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Tianjin Zhongfuan Technology Nuclear Medicine Shielded Equipment Product Offerings
7.11.5 Tianjin Zhongfuan Technology Recent Development
7.12 Beijing Goyuan New Technology
7.12.1 Beijing Goyuan New Technology Company Information
7.12.2 Beijing Goyuan New Technology Introduction and Business Overview
7.12.3 Beijing Goyuan New Technology Nuclear Medicine Shielded Equipment Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Beijing Goyuan New Technology Nuclear Medicine Shielded Equipment Product Offerings
7.12.5 Beijing Goyuan New Technology Recent Development
7.13 Sunvic
7.13.1 Sunvic Company Information
7.13.2 Sunvic Introduction and Business Overview
7.13.3 Sunvic Nuclear Medicine Shielded Equipment Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Sunvic Nuclear Medicine Shielded Equipment Product Offerings
7.13.5 Sunvic Recent Development
8 Industry Chain Analysis
8.1 Nuclear Medicine Shielded Equipment Industrial Chain
8.2 Nuclear Medicine Shielded Equipment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Nuclear Medicine Shielded Equipment Sales Model
8.5.2 Sales Channel
8.5.3 Nuclear Medicine Shielded Equipment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Nuclear Medicine Shielded Equipment market is projected to grow from US$ 136 million in 2025 to US$ 234 million by 2032, at a CAGR of 8.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-11
Pages: 154
USD 4900.00
(Single User License)
The global Nuclear Medicine Shielded Equipment market was valued at US$ 136 million in 2025 and is anticipated to reach US$ 234 million by 2032, at a CAGR of 8.2% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 119
USD 2900.00
(Single User License)
The global Nuclear Medicine Shielded Equipment market size was US$ 136 million in 2025 and is forecast to reach a readjusted size of US$ 234 million by 2032 with a CAGR of 8.2% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 97
USD 4250.00
(Single User License)
The global market for Nuclear Medicine Shielded Equipment was estimated to be worth US$ 136 million in 2025 and is projected to reach US$ 234 million, growing at a CAGR of 8.2% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 127
USD 3950.00
(Single User License)
The global Nuclear Medicine Shielded Equipment market size was US$ 128 million in 2024 and is forecast to a readjusted size of US$ 218 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.
Published Date: 2025-05-02
Pages: 93
USD 4250.00
(Single User License)
The global Nuclear Medicine Shielded Equipment market is projected to grow from US$ 136 million in 2025 to US$ 218 million by 2031, at a Compound Annual Growth Rate (CAGR) of 8.2% during the forecast period.
Published Date: 2025-05-02
Pages: 153
USD 4900.00
(Single User License)
The global market for Nuclear Medicine Shielded Equipment was valued at US$ 128 million in the year 2024 and is projected to reach a revised size of US$ 218 million by 2031, growing at a CAGR of 8.2% during the forecast period.
Published Date: 2025-05-02
Pages: 95
USD 2900.00
(Single User License)
The global Nuclear Medicine Shielded Equipment market is projected to grow from US$ 136 million in 2025 to US$ 234 million by 2032, at a CAGR of 8.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-11
Pages: 154
The global Nuclear Medicine Shielded Equipment market was valued at US$ 136 million in 2025 and is anticipated to reach US$ 234 million by 2032, at a CAGR of 8.2% from 2026 to 2032.
Published: 2026-03-11
Pages: 119
The global Nuclear Medicine Shielded Equipment market size was US$ 136 million in 2025 and is forecast to reach a readjusted size of US$ 234 million by 2032 with a CAGR of 8.2% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 97
The global market for Nuclear Medicine Shielded Equipment was estimated to be worth US$ 136 million in 2025 and is projected to reach US$ 234 million, growing at a CAGR of 8.2% from 2026 to 2032.
Published: 2026-03-09
Pages: 127
The global Nuclear Medicine Shielded Equipment market size was US$ 128 million in 2024 and is forecast to a readjusted size of US$ 218 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.
Published: 2025-05-02
Pages: 93
The global Nuclear Medicine Shielded Equipment market is projected to grow from US$ 136 million in 2025 to US$ 218 million by 2031, at a Compound Annual Growth Rate (CAGR) of 8.2% during the forecast period.
Published: 2025-05-02
Pages: 153
The global market for Nuclear Medicine Shielded Equipment was valued at US$ 128 million in the year 2024 and is projected to reach a revised size of US$ 218 million by 2031, growing at a CAGR of 8.2% during the forecast period.
Published: 2025-05-02
Pages: 95
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now